Skip to main content
. 2016 Dec 19;107(12):1867–1876. doi: 10.1111/cas.13092

Figure 6.

Figure 6

Co‐expression of hepatocyte growth factor (HGF) and c‐MET correlates with a poor prognosis in patients with synovial sarcoma (SS). (a) HGF and c‐MET expression in SS clinical samples. Scale bars: 100 μm. (b) Overall survival curve in SS patients whose tumors co‐expressed HGF and c‐MET (n = 15) and the other patients (n = 27). (c) Metastasis‐free survival curve in SS patients with localized diseases at initial diagnosis whose tumors were positive for both HGF and c‐MET (n = 7) and the other patients (n = 22).